Novo Nordisk NVO shares have rallied 11.2% over a month as investors regained confidence in the company's obesity growth ...

But at this stage of Eli Lilly's crucial obesity-drug business, the greenest pastures are currently overseas.

Although Viking Therapeutics VKTX isn’t officially on the auction block, investors are increasingly viewing it as a potential ...

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

The Green Revolution’s genius was carbohydrate abundance. Its unintended bequest is a carbohydrate-dependent plate. The 2023 ...

Discover 5 top Big Pharma stocks amid rising cancer, type 2 diabetes and IMIDs—dividend yields, earnings beats and why they ...

Alphabet may be the Dow's newest member, but these three dividend-paying Dow stocks look like the better buys for income ...

The Medicare GLP-1 Bridge will start July 1. Regardless of the balance sheet, the responsible choice, says Dr Amy Faith Ho, is not to wait until obesity becomes a heart attack, a dialysis chair, or ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

Risk factors for cardiovascular disease have been formally identified for over six decades. Providing education and targeting therapeutic approaches against these risk factors have been responsible ...

A new study suggests using body mass index alone may miss many people with the disease, but the findings come with caveats. By Nina Agrawal New research using an updated definition of obesity suggests ...